AMCPX
Price
$43.62
Change
+$0.37 (+0.86%)
Updated
Jan 17 closing price
Net Assets
90.68B
GFACX
Price
$65.90
Change
+$0.75 (+1.15%)
Updated
Jan 17 closing price
Net Assets
306.54B
Ad is loading...

AMCPX vs GFACX

Header iconAMCPX vs GFACX Comparison
Open Charts AMCPX vs GFACXBanner chart's image
American Funds AMCAP A
Price$43.62
Change+$0.37 (+0.86%)
VolumeN/A
Net Assets90.68B
American Funds Growth Fund of Amer C
Price$65.90
Change+$0.75 (+1.15%)
VolumeN/A
Net Assets306.54B
AMCPX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMCPX vs. GFACX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMCPX is a Buy and GFACX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 307B vs. AMCPX (90.7B). AMCPX pays higher dividends than GFACX: AMCPX (0.50) vs GFACX (0.00). AMCPX was incepted earlier than GFACX: AMCPX (58 years) vs GFACX (24 years). AMCPX (31.00) and GFACX (31.00) have comparable annual turnover. AMCPX (250) and GFACX (250) have matching initial minimum investment requirements. GFACX annual gain was more profitable for investors over the last year : 19.88 vs. AMCPX (14.62). GFACX return over 5 years is better than : 36.07 vs. AMCPX (26.95).
AMCPXGFACXAMCPX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence58 years24 years-
Gain YTD2.1073.35663%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets90.7B307B30%
Annual Yield % from dividends0.500.00-
Returns for 1 year14.6219.8874%
Returns for 3 years6.387.8082%
Returns for 5 years26.9536.0775%
Returns for 10 years59.9565.6291%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XYF7.430.16
+2.20%
X Financial
VIV8.060.10
+1.26%
Telefonica Brasil SA
DNLI21.930.26
+1.20%
Denali Therapeutics
BLFS26.14-0.31
-1.17%
BioLife Solutions
BRTX1.97-0.06
-2.72%
BioRestorative Therapies